Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Borås
Clinical trial register · Sweden

Clinical Trials in Borås, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC4 Sahlgrenska University Hospital4 Genmab4 Uppsala University3 AbbVie3
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Borås

48 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
Karolinska Institutet
Phase 3
1,100
Borås, Skövde, Stockholm
2026-04-14
Recruiting
Uppsala University
Phase 4
560
Borås, Eskilstuna, Gothenburg, Karlskrona, Lund, Örebro, Stockholm, Sundsvall
2025-12
Recruiting
Vastra Gotaland Region
Not applicable
132
Borås, Gothenburg
2025-10-01
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Lund, Borås, Uppsala
2025-09-22
Recruiting
Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest
NCT07174986Out of Hospital Cardiac Arrest, Ventricular Fibrillation, Defibrillation, CPR
Gabriel Riva
Phase 2/3
916
Halmstad, Karlstad, Kungälv, Alingsås, Borås, Gothenburg, Skövde, Trollhättan
2025-09-08
Recruiting
Sahlgrenska University Hospital
Observational
420
Borås, Gothenburg, Malmö
2025-09-01
Recruiting
AbbVie
Phase 1/2
325
Solna, Borås, Gothenburg
2025-07-23
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Borås, Falun, Gothenburg, Halmstad, Karlstad, Ljungby, Malmö, Södertälje
2025-07-22
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Malmö, Stockholm, Uppsala, Borås
2025-06-30
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Gävle, Stockholm, Uppsala, Borås, Gothenburg
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Stockholm, Uppsala, Borås
2024-04-14
Active, closed
Genmab
Phase 3
1,095
Borås, Gothenburg
2024-02-05
Recruiting
Lina Bergman
Phase 3
294
Borås, Falun, Gothenburg, Linköping, Lund, Malmö, Skövde, Stockholm
2024-01-19
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Borås, Lund, Stockholm
2023-12-15
Active, closed
Ipsen
Observational
1,057
Ängelholm, Borås, Malmö, Skövde
2023-11-01
Recruiting
The Patient's First Point of Contact
NCT06067672Nurse-Patient Relations
University of Boras
Observational
150
Borås
2023-08-15
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Borås, Uddevalla
2023-06-22
Recruiting
Region Skane
Not applicable
1,350
Borås, Eskilstuna, Gävle, Gothenburg, Halmstad, Jönköping, Kalmar, Karlstad
2023-03-17
Active, closed
Genmab
Phase 3
900
Lund, Solna, Borås, Gothenburg, Linköping
2023-02-08
Active, closed
Ixekizumab Diabetes Intervention Trial (I-DIT)
NCT04589325Type1 Diabetes Mellitus
DrugsTaltz·Ixekizumab
Göteborg University
Phase 2
127
Borås, Falun, Gothenburg, Jönköping, Karlstad, Kristianstad, Linköping, Lund
2022-11-09
Active, closed
Genmab
Phase 3
549
Luleå, Borås, Linköping
2022-09-20
Active, closed
GlaxoSmithKline
Phase 3
3,038
Borås, Gothenburg, Karlskrona, Linköping, Malmö, Örebro, Stockholm, Upplands Vasby
2022-08-10
Active, closed
Celgene
Phase 3
939
Borås, Helsingborg
2022-06-23
Active, closed
Sanofi
Phase 3
531
Borås, Huddinge
2022-06-23
Active, closed
Pfizer
Phase 3
854
Helsingborg, Stockholm, Borås, Falun, Örebro, Linköping
2022-03-25
Active, closed
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction
NCT05024864Myocardial Infarction, Helicobacter Pylori Infection, GastroIntestinal Bleeding, Cardiovascular Diseases
Karolinska Institutet
Not applicable
20,000
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Halmstad, Helsingborg, Jönköping
2021-11-17
Recruiting
Pfizer
Phase 3
893
Lund, Borås, Falun, Gothenburg, Luleå, Örebro, Linköping
2021-10-04
Active, closed
8-day Intensive Treatment Programme for PTSD and CPTSD in Sweden
NCT06645028PTSD, Complex Post-Traumatic Stress Disorder
Christina Blomdahl
Not applicable
118
Borås
2021-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Stockholm, Borås
2021-06-18
Active, closed
German CLL Study Group
Phase 3
897
Borås, Falun, Gothenburg, Halmstad, Linköping, Luleå, Lund, Örebro
2021-03-01
Recruiting
Sahlgrenska University Hospital
Observational
1,000
Borås, Gothenburg
2020-11-27
Active, closed
Genmab
Phase 1/2
543
Borås, Gothenburg, Lund, Solna, Uppsala
2020-11-03
Recruiting
Nordic Lymphoma Group
Phase 3
300
Borås, Gothenburg, Halmstad, Kalmar, Linköping, Lund, Örebro, Södra Sunderbyn
2020-08-19
Active, closed
COPE - COVID-19 in Pregnancy and Early Childhood
NCT04433364Sars-CoV2, Covid-19, Pregnancy Complications, Pregnancy Preterm
Sahlgrenska University Hospital
Observational
3,834
Falun, Halmstad, Varberg, Helsingborg, Lund, Eskilstuna, Borås, Gothenburg
2020-06-02
Active, closed
Remote Exercise SWEDEHEART Study
NCT04260958Myocardial Infarction
Sahlgrenska University Hospital
Not applicable
1,500
Borås, Eskilstuna, Falun, Gällivare, Gävle, Gothenburg, Hässleholm, Jönköping
2020-02-03
Active, closed
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
NCT04335669Breast Cancer, Triple Negative Breast Neoplasms
Lund University Hospital
Phase 3
325
Kristianstad, Borås, Gävle, Gothenburg, Halmstad, Jönköping, Karlstad, Malmö
2019-12-20
Recruiting
Uppsala University
Not applicable
1,440
Uppsala, Alingsås, Borås, Falun, Gävle, Gothenburg, Jönköping, Kalmar
2019-09-16
Recruiting
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
NCT03903835Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
DrugsXofigo·Cabazitaxel·Zytiga·Capivasertib
Karolinska Institutet
Phase 3
750
Falun, Borås, Jönköping, Kalmar, Karlstad, Örebro, Stockholm, Sundsvall
2019-02-01
Active, closed
Optimal Treatment Protocol for Selective Laser Trabeculoplasty
NCT03798223Glaucoma, Open-Angle, Pseudoexfoliation Glaucoma, Ocular Hypertension
Vastra Gotaland Region
Not applicable
400
Borås, Mölndal, Skövde, Uddevalla
2019-01-10
Active, closed
AbbVie
Phase 3
265
Luleå, Borås, Linkoping, Uddevalla
2018-10-22
Active, closed
Raija Silvennoinen
Phase 2
120
Borås, Gothenburg, Halmstad, Linköping, Luleå, Lund, Örebro, Skåne
2018-05-31
Active, closed
AbbVie
Phase 3
747
Halmstad, Solna, Alingsås, Borås, Gothenburg
2018-03-21
Active, closed
BeiGene
Phase 3
590
Borås, Gothenburg, Lund, Örebro, Stockholm, Uppsala
2017-10-31
Recruiting
Uppsala University
Not applicable
1,300
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Helsingborg, Jönköping, Kalmar
2017-06-08
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
DrugIbrutinib
Pharmacyclics Switzerland GmbH
Phase 4
297
Luleå, Borås, Solna
2017-05-22
Active, closed
University Medical Center Groningen
Phase 3
920
Borås, Eskilstuna, Falun, Gävle, Gothenburg, Kalmar, Karlstad, Linköping
2011-06-21
Recruiting
Lund University
Observational
20,000
Borås, Halmstad, Helsingborg, Jönköping, Karlskrona, Kristianstad, Lund, Malmö
2010-08
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Borås, Malmö, Norrköping
1991-04-01
Rows per page Showing 1–48 of 48
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/bor-s

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 48 of those studies with a site in Borås.

How many clinical trials are recruiting in Borås?

23 of the 48 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 25 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Borås), 48 studies
PhaseStudiesRecruitingShare
Phase 3261154.2%
Not applicable8416.7%
Observational7514.6%
Phase 1/2214.2%
Phase 2204.2%
Phase 4214.2%
Phase 2/3112.1%

Most active sponsors

Lead sponsors with the most studies (Borås)
Lead sponsorStudiesRecruiting
Genmab40
Merck Sharp & Dohme LLC43
Sahlgrenska University Hospital42
AbbVie31
Karolinska Institutet32
Uppsala University33
Bristol-Myers Squibb21
Pfizer21
Vastra Gotaland Region21
BeiGene10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.